เอกสารอ้างอิง
1. Srivatanakul P. Cervix uteri. In: Khuhaprema T, Srivatanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P, editors. Cancer in Thailand. 1998-2000. Vol. IV. Bangkok: Bangkok Medical Publisher, 2007: 51-3.
2. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organized screening programmes. Lancet 1987; 1: 1247-9.
3. Sigurdsson K. Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991. Int J Cancer 1993; 54: 563-70.
4. The Royal Thai College of Obstetricians and Gynecologist (RTCOG)/Jhpiego Corporation Cervical Cancer Prevention Group (JCCCPG). Safety, acceptability and feasibility of a single-visit approach to cervical cancer prevention in rural Thailand: a demonstration project. Lancet 2003; 361: 814-20.
5. Chumworathayi B, Eamratsameekool W, Kularbkaew C, Chumworathayi P. Visual inspection with acetic acid test qualities in a secondary setting. J Obstet Gynaecol Res 2008; 34: 909-13.
6. Sanghvi H, Limpaphayom KK, Plotkin M, Charurat E, Kleine A, Lu E, et al. Cervical cancer screening using visual inspection with acetic acid: operational experiences from Ghana and Thailand. Reprod Health Matters 2008; 16: 67-77.
7. Gaffikin L, Lauterbach M, Blumenthal PD. Performance of visual inspection with acetic acid for cervical cancer screening a qualitative summary of evidence to date. Obstet Gynecol Surv 2003; 58: 543-50.
8. American College of Obstetricians and Gynecologist. ACOG statement of policy: cervical cancer prevention in low-resource setting. Obstet Gynecol 2004; 103: 607-9.
9. Martin-Hirsch PL, Paraskevaidis E, Kitchener H. Surgery for cervical intraepithelial neoplasia (Cochrane reviews). In: The Cochrane Library, Issue 4, 2000. Oxford: Update Software.
10. Effectiveness, safety and acceptability of cryotherapy: a systematic literature review. Available at http://www.path.org/files/RH-cryo-white-paper.pdf. [Access June 1, 2009].
11. เพชรินทร์ ศรีวัฒนกุล, ธีรวุฒิ คูหะเปรมะ, สมยศ ดีรัศมี, บรรณาธิการ. แผนการดำเนินงานการป้องกันและควบคุมโรคมะเร็งปากมดลูกที่เหมาะสมในประเทศไทย. กรุงเทพฯ: บริษัทรำไทยเพรสจำกัด; 2548.
12. Chumworathayi B, Limpaphayom KK, Srisupundit S, Lumbiganon P. VIA and cryotherapy: doing whats best. J Med Assoc Thai 2006; 88: 1333-9.
13. Sankaranayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, et al. Accuracy of visual screening of cervical neoplasia: result from an IARC multicenter study in India and Africa. Int J Cancer 2004; 110: 907-13.
14. Solomon D, Davey D , Kurman R , Moriarty A , OConnor D , Prey M , et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-9.
15. Screening test. In: IARC Handbooks of cancer prevention Vol. 10. Cervix Cancer Screening. Lyon: IARC Press; 2005.
16. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995; 141: 680-9.
17. Chumworathayi B, Tomuen C. Can Pap smear exclude the need for colposcopy in referred VIA-positive cases? Int J Canc Prev 2008; 2: 357-61.